CN110702836B - 一种类神经酰胺发酵提取物的检测方法及其应用 - Google Patents
一种类神经酰胺发酵提取物的检测方法及其应用 Download PDFInfo
- Publication number
- CN110702836B CN110702836B CN201911116249.8A CN201911116249A CN110702836B CN 110702836 B CN110702836 B CN 110702836B CN 201911116249 A CN201911116249 A CN 201911116249A CN 110702836 B CN110702836 B CN 110702836B
- Authority
- CN
- China
- Prior art keywords
- mel
- ceramide
- solution
- fermentation extract
- fermentation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 104
- 230000004151 fermentation Effects 0.000 title claims abstract description 104
- 239000000284 extract Substances 0.000 title claims abstract description 84
- 238000001514 detection method Methods 0.000 title claims abstract description 14
- JCYZMTMYPZHVBF-UHFFFAOYSA-N Melarsoprol Chemical compound NC1=NC(N)=NC(NC=2C=CC(=CC=2)[As]2SC(CO)CS2)=N1 JCYZMTMYPZHVBF-UHFFFAOYSA-N 0.000 claims abstract description 59
- 229940106189 ceramide Drugs 0.000 claims abstract description 43
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims abstract description 40
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims abstract description 40
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims abstract description 40
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims abstract description 38
- 238000000034 method Methods 0.000 claims abstract description 26
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 10
- 238000004809 thin layer chromatography Methods 0.000 claims abstract description 9
- 239000000243 solution Substances 0.000 claims description 45
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 36
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 33
- 239000012085 test solution Substances 0.000 claims description 31
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 24
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 21
- 239000012088 reference solution Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 15
- 238000010828 elution Methods 0.000 claims description 14
- 239000011259 mixed solution Substances 0.000 claims description 11
- 238000000105 evaporative light scattering detection Methods 0.000 claims description 10
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 9
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 9
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000013558 reference substance Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 8
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000010812 external standard method Methods 0.000 claims description 4
- 239000000945 filler Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 229910000069 nitrogen hydride Inorganic materials 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 230000000007 visual effect Effects 0.000 abstract description 2
- 230000001580 bacterial effect Effects 0.000 description 30
- 239000000725 suspension Substances 0.000 description 24
- 238000012360 testing method Methods 0.000 description 21
- 238000011218 seed culture Methods 0.000 description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- 239000000839 emulsion Substances 0.000 description 16
- 239000000523 sample Substances 0.000 description 16
- 239000012071 phase Substances 0.000 description 14
- 238000000926 separation method Methods 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- 239000003208 petroleum Substances 0.000 description 9
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 8
- -1 amide compounds Chemical class 0.000 description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 5
- 150000001783 ceramides Chemical class 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 238000004945 emulsification Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000004006 olive oil Substances 0.000 description 4
- 235000008390 olive oil Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 241001052560 Thallis Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241001661345 Moesziomyces antarcticus Species 0.000 description 2
- YDNKGFDKKRUKPY-TURZORIXSA-N N-hexadecanoylsphingosine Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)\C=C\CCCCCCCCCCCCC YDNKGFDKKRUKPY-TURZORIXSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000003876 biosurfactant Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 150000002339 glycosphingolipids Chemical class 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical class O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 239000005504 Dicamba Substances 0.000 description 1
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- 241001661343 Moesziomyces aphidis Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 125000001549 ceramide group Chemical group 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical group C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 description 1
- 229950004354 phosphorylcholine Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
测定次数 | Mel-A | Mel-B | Mel-C |
1 | 11884355 | 11767623 | 11675306 |
2 | 11894588 | 11683175 | 11531208 |
3 | 11860617 | 11788125 | 11616256 |
4 | 11881863 | 11672033 | 11590152 |
5 | 11905583 | 11742945 | 11600074 |
6 | 11799615 | 11691795 | 11650822 |
平均值 | 11871104 | 11724283 | 11610636 |
RSD% | 0.32 | 0.41 | 0.43 |
测定时间 | Mel-A | Mel-B | Mel-C |
0 | 7678217 | 10107590 | 12519431 |
1 | 7358482 | 10307641 | 12472144 |
2 | 7501775 | 10293072 | 12610011 |
4 | 7479343 | 9990326 | 12460289 |
8 | 7583817 | 10151031 | 12538759 |
24 | 7507163 | 9957786 | 12193176 |
平均值 | 7518133 | 10134574 | 12465635 |
RSD% | 1.42 | 1.45 | 1.13 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911116249.8A CN110702836B (zh) | 2019-11-15 | 2019-11-15 | 一种类神经酰胺发酵提取物的检测方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911116249.8A CN110702836B (zh) | 2019-11-15 | 2019-11-15 | 一种类神经酰胺发酵提取物的检测方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110702836A CN110702836A (zh) | 2020-01-17 |
CN110702836B true CN110702836B (zh) | 2021-12-07 |
Family
ID=69206959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911116249.8A Active CN110702836B (zh) | 2019-11-15 | 2019-11-15 | 一种类神经酰胺发酵提取物的检测方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110702836B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102778528A (zh) * | 2012-08-30 | 2012-11-14 | 上海奥利实业有限公司 | 类神经酰胺含量的测定方法 |
CN102914603A (zh) * | 2012-09-27 | 2013-02-06 | 苏州市产品质量监督检验所 | 一种同时分离检测十三种糖和糖醇的高效液相色谱蒸发光散射检测法 |
CN103589764A (zh) * | 2013-11-05 | 2014-02-19 | 浙江大学 | 一种甘露糖赤藓糖醇脂的生产方法 |
CN108619996A (zh) * | 2018-04-26 | 2018-10-09 | 南京理工大学 | 一种甘露糖赤癣糖醇脂的分离纯化方法 |
-
2019
- 2019-11-15 CN CN201911116249.8A patent/CN110702836B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102778528A (zh) * | 2012-08-30 | 2012-11-14 | 上海奥利实业有限公司 | 类神经酰胺含量的测定方法 |
CN102914603A (zh) * | 2012-09-27 | 2013-02-06 | 苏州市产品质量监督检验所 | 一种同时分离检测十三种糖和糖醇的高效液相色谱蒸发光散射检测法 |
CN103589764A (zh) * | 2013-11-05 | 2014-02-19 | 浙江大学 | 一种甘露糖赤藓糖醇脂的生产方法 |
CN108619996A (zh) * | 2018-04-26 | 2018-10-09 | 南京理工大学 | 一种甘露糖赤癣糖醇脂的分离纯化方法 |
Non-Patent Citations (1)
Title |
---|
Identification of Pseudozyma graminicola CBS 10092 as a Producer of Glycolipid Biosurfactants, Mannosylerythritol Lipids;Tomotake Morita等;《Journal of Oleo Science》;20080228;第57卷(第2期);摘要,第2.4节,第2.5节,第3.2节,图3 * |
Also Published As
Publication number | Publication date |
---|---|
CN110702836A (zh) | 2020-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108245508A (zh) | 一种海洋真菌土曲霉丁内酯类化合物丁内酯-i的制备方法和应用 | |
CN108802255B (zh) | 测定复方制剂中灵芝三萜类成分含量的方法 | |
CN106596774A (zh) | 一种生防菌挥发性代谢物的检测方法 | |
CN115716790B (zh) | 马齿苋中一种酰胺酯类生物碱的提取分离方法及其应用 | |
CN110702836B (zh) | 一种类神经酰胺发酵提取物的检测方法及其应用 | |
CN109725068B (zh) | 高效测定神经节苷脂gm1及其杂质的药物分析方法 | |
Hungeling et al. | Cyanogenic and non-cyanogenic pyridone glucosides from Acalypha indica (Euphorbiaceae) | |
Brooks et al. | Toxic phorbol esters from Chinese tallow stimulate protein kinase C | |
CN112280806A (zh) | 一种通过乳化发酵制备类神经酰胺的方法及其应用 | |
CN109265494B (zh) | 从滇山茶中提取山奈酚葡萄糖苷类化合物的方法 | |
CN101609069A (zh) | 一种用hplc法测定恩替卡韦及其药用组合物有关物质的方法 | |
CN103207256B (zh) | 坛紫菜中红藻糖苷和异红藻糖苷含量的检测方法 | |
CN102636612A (zh) | 一种分析骆驼蓬草中有效成分的方法 | |
CN1323078C (zh) | 用于控制衰老和应激的药理活性的新型持久信息素化合物及分离和表征它的方法 | |
CN101672831A (zh) | 总芸苔素含量的液相色谱测定方法 | |
CN100480697C (zh) | 由灯盏花素、双嘧达莫制成的注射剂的质量控制方法 | |
CN103421856A (zh) | 一种t-2毒素的生物合成方法 | |
CN113416123B (zh) | 一种多孢木霉菌株分离的单体化合物、制备方法及应用 | |
CN106748778B (zh) | 具有降血糖作用的一种新联苄类天然药物及其制备方法和用途 | |
CN106748664B (zh) | 具有降血糖作用的新联苄类天然药物及其用途 | |
CN113461532B (zh) | 一种具有降血糖作用的黑桑素a及其制备方法和应用 | |
CN117269375B (zh) | 一种测定维生素a醋酸酯粉中有关物质的方法 | |
CN115960029B (zh) | 一种假松茸中生物碱及其提取分离方法和应用 | |
CN103450307A (zh) | 一种制备海龙中胆甾-4-烯-3-酮的高纯度单体的方法 | |
CN113156017B (zh) | 一种采用hplc法同时测定强力定眩片中12种化学成分含量的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240514 Address after: Room 1A102, No. 55 Yuncheng West Road, Baiyun District, Guangzhou City, Guangdong Province, 510420 Patentee after: Guangzhou Meichangwan Biopharmaceutical Technology Co.,Ltd. Country or region after: China Address before: 510550 Building No.1, 785 Guangcong Eighth Road, Baiyun District, Guangzhou City, Guangdong Province Patentee before: GUANGDONG XIANDAI HANFANG TECHNOLOGY Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |